Willingness to take the Covid-19 vaccines and associated factors at a tertiary institution community in Johannesburg, South Africa

Abstract

AbstractBackgroundSA is aiming to achieve herd immunity against Covid-19 by the first quarter of 2022. The success of the Covid-19 vaccination roll-out depends primarily on the willingness of the population to take the vaccines.AimThis study examined the willingness to take the Covid-19 vaccine, along with the factors of concern, efficacy, and preferences of the individual which may increase the willingness to be vaccinated.SettingThis study was conducted at the University of the Witwatersrand, Johannesburg, amongst adult students and academic and professional staff.MethodsWe conducted a cross-sectional online study from 27 July – 14 August 2021. We performed descriptive and inferential analysis to determine the factors associated with willingness to take the Covid-19 vaccine.Results2364 participants responded to a survey link and 82% were students, 66.8% were in the 18-29 years age band, females represented 64.0% and 49.2% were black people. 1965 (83.3%) were willing to receive a Covid-19 vaccine, the most preferred vaccines were Pfizer (41%) and J&J (23%), local pharmacy (29%) and GP (17%) were the preferred places for vaccination and the trusted sources of information on Covid-19 vaccines were the general practitioners (40.6%) and specialists (19,2%). Perceptions that vaccines are safe (aOR=31.56, 95%CI: 16.02-62.12 for affirmative agreement) and effective (aOR=5.92, 95%CI: 2.87-12.19 for affirmative agreement) were the main determinants for willingness to taking a COVID-19 vaccineConclusionIt is imperative to reinforce the message of Covid-19 vaccine safety and efficacy and to include the GPs and the community pharmacies in the vaccination roll-out in SA.